Final Results of First European Phase Ii Trial of Intravenous Cetuximab (Cet) and Hepatic Artery Infusion of Irinotecan, 5-Fluorouracil, and Oxaliplatin in Patients (Pts) with Unresectable Liver Metastases from Wt Kras Colorectal Cancer (Lm-Crc) After Systemic Treatment Failure (Optiliv, Nct00852228).

AuthID
 P-00P-8P8
20
Author(s)
Smith, D
·
Lepere, C
·
Focan, CNJ
·
Guimbaud, R
·
Carvalho, C
·
Tumolo, S
·
Innominato, PF
·
Ajavon, Y
·
Truant, S
·
Castaing, D
·
De Baere, T
·
Kunstlinger, F
·
Karaboue, A
·
Bouchahda, M
·
Rougier, PR
·
Adam, R
·
Ducreux, M
1
Group Author(s)
ARTBC Int
Tipo de Documento
Abstract
Year published
2013
Publicado
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 31, Número: 4
Conference
Gastrointestinal Cancers Symposium of the American-Society-Of-Clinical-Oncology (Asco), Date: JAN 24-26, 2013, Location: San Francisco, CA, Patrocinadores: Amer Soc Clin Oncol
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000333679000457
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service